Tags |
|
|
Links |
|
|
Subjects - Competition in the Online Press Release Website Venue
When looking at all the many Press-Release Websites out on the In
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
ternet today one would have to ask is the field already too crowd
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
d? Is another press release website a valid concept? Well sure it
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
is a viable concept and sure there is competition, there is compe
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
ition on everything. Lets say an online article submission websit
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
or online business article website launched an online press rele
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
se website? Would that be a significant enough niche to make it a
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
viable add-on?
Well, if online submission sites goals are to div
Well, if online submission sites goals are to div
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
rt the 1000s of rejects of articles, which are clearly way too co
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
mercial then it might make sense. Of course once the secondary si
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
e was added you must give adequate exposure to the diverted artic
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
le and the author. If you are diverting without delivery of Incre
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
sed Press Exposure, you could be said to be tricking folks, tryin
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
to appease them instead of being strict and simply saying NO, ta
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
e your salesy article elsewhere.
But also realize that some arti
But also realize that some arti
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
le authors only wish to write self promoting articles that cross
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
n online article submission sites editorial lines and borders of
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
cceptability. Nevertheless, such a secondary market is of value a
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
d could develop a following of authors who used it exclusively wi
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
h only a few regular articles on this site. Consider this in 2006
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.subjects.org.ua/article/86825/subjects-Competition-in-the-Online-Press-Release-Website-Venue.html">Competition in the Online Press Release Website Venue</a>
BB link (for phorums):
[url=http://www.subjects.org.ua/article/86825/subjects-Competition-in-the-Online-Press-Release-Website-Venue.html]Competition in the Online Press Release Website Venue[/url]
Related Articles:
Integrate Your Affiliate Programs to Explode Your Affiliate Income
Fitnesscasting - The Commercial Application of Podcasting for the Health and Fitness Community
Bookmark it:
|